Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
|
CN |
|
D
|
Danieli & C Officine Meccaniche SpA
MIL:DAN
|
IT |
|
Linedata Services SA
PAR:LIN
|
FR |
|
N
|
NIFTY Lifestyle Co Ltd
TSE:4262
|
JP |
|
M
|
MPX Logistics International Tbk PT
IDX:MPXL
|
ID |
|
Rakus Co Ltd
TSE:3923
|
JP |
|
Polski Koncern Naftowy Orlen SA
WSE:PKN
|
PL |
|
Y
|
Yangtze Optical Fibre and Cable Joint Stock Ltd Co
OTC:YZOFF
|
CN |
|
G
|
Glaston Oyj Abp
OMXH:GLA1V
|
FI |
|
S
|
Shenzhen CECport Technologies Co Ltd
SZSE:001287
|
CN |
|
B
|
Bergman & Beving AB
STO:BERG B
|
SE |
|
H
|
Hlt Global Bhd
KLSE:HLT
|
MY |
|
Beijing Zhidemai Technology Co Ltd
SZSE:300785
|
CN |
|
J
|
Jiangsu Boxin Investing & Holdings Co Ltd
SSE:600083
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hefei Lifeon Pharmaceutical Co Ltd's stock price target?
Not Available
Hefei Lifeon Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hefei Lifeon Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
26%
For the last 6 years the
compound annual growth rate for
Hefei Lifeon Pharmaceutical Co Ltd's revenue is
1%.
The projected
CAGR
for the next 2 years is
26%.
What is Hefei Lifeon Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
80%
For the last 6 years the
compound annual growth rate for
Hefei Lifeon Pharmaceutical Co Ltd's net income is
10%.
The projected
CAGR
for the next 2 years is
80%.
